SMS Pharmaceuticals Limited (IN:SMSPHARMA)
:SMSPHARMA
Want to see IN:SMSPHARMA full AI Analyst Report?
Total Valuation
SMS Pharmaceuticals Limited has a market cap or net worth of ₹35.24B. The enterprise value is ₹38.40B.
Market Cap₹35.24B
Enterprise Value₹38.40B
Share Statistics
SMS Pharmaceuticals Limited has 93,652,030 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding93,652,030
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
SMS Pharmaceuticals Limited’s return on equity (ROE) is 0.13 and return on invested capital (ROIC) is 8.53%.
Return on Equity (ROE)0.13
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)8.53%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee7.41M
Profits Per Employee852.04K
Employee Count1,197
Asset Turnover0.65
Inventory Turnover2.03
Valuation Ratios
The current PE Ratio of SMS Pharmaceuticals Limited is 33.3. SMS Pharmaceuticals Limited’s PEG ratio is 0.91.
PE Ratio33.3
PS Ratio3.87
PB Ratio4.36
Price to Fair Value4.36
Price to FCF-37.01
Price to Operating Cash Flow81.45
PEG Ratio0.91
Income Statement
In the last 12 months, SMS Pharmaceuticals Limited had revenue of 8.87B and earned 1.02B in profits. Earnings per share was 11.15.
Revenue8.87B
Gross Profit1.75B
Operating Income1.31B
Pretax Income1.31B
Net Income1.02B
EBITDA1.71B
Earnings Per Share (EPS)11.15
Cash Flow
In the last 12 months, operating cash flow was 423.25M and capital expenditures -296.67M, giving a free cash flow of 126.58M billion.
Operating Cash Flow423.25M
Free Cash Flow126.58M
Free Cash Flow per Share1.35
Dividends & Yields
SMS Pharmaceuticals Limited pays an annual dividend of ₹0.4, resulting in a dividend yield of 0.13%
Dividend Per Share₹0.4
Dividend Yield0.13%
Payout Ratio4.17%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.59
52-Week Price Change50.34%
50-Day Moving Average393.06
200-Day Moving Average337.55
Relative Strength Index (RSI)46.86
Average Volume (3m)105.50K
Important Dates
SMS Pharmaceuticals Limited upcoming earnings date is Aug 10, 2026, TBA (Confirmed).
Last Earnings DateMay 22, 2026
Next Earnings DateAug 10, 2026
Ex-Dividend Date―
Financial Position
SMS Pharmaceuticals Limited as a current ratio of 1.81, with Debt / Equity ratio of 46.46%
Current Ratio1.81
Quick Ratio0.81
Debt to Market Cap0.11
Net Debt to EBITDA1.86
Interest Coverage Ratio5.69
Taxes
In the past 12 months, SMS Pharmaceuticals Limited has paid 286.40M in taxes.
Income Tax286.40M
Effective Tax Rate0.22
Enterprise Valuation
SMS Pharmaceuticals Limited EV to EBITDA ratio is 21.88, with an EV/FCF ratio of -40.45.
EV to Sales4.23
EV to EBITDA21.88
EV to Free Cash Flow-40.45
EV to Operating Cash Flow98.85
Balance Sheet
SMS Pharmaceuticals Limited has ₹1.02B in cash and marketable securities with ₹3.24B in debt, giving a net cash position of -₹2.22B billion.
Cash & Marketable Securities₹1.02B
Total Debt₹3.24B
Net Cash-₹2.22B
Net Cash Per Share-₹23.73
Tangible Book Value Per Share₹85.91
Margins
Gross margin is 25.68%, with operating margin of 14.81%, and net profit margin of 11.50%.
Gross Margin25.68%
Operating Margin14.81%
Pretax Margin14.73%
Net Profit Margin11.50%
EBITDA Margin19.31%
EBIT Margin14.81%
Analyst Forecast
The average price target for SMS Pharmaceuticals Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast13.30%
EPS Growth Forecast39.45%